Trial Profile
Safety and efficacy of Sacubitril/Valsartan in Patients with Congestive Heart Failure Who are Eligible for Heart Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 20 Apr 2017 New trial record
- 08 Apr 2017 Results presented at the 37th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation